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SUMMARY
Chronic, remittent, erosive arthritis was produced in rats by a single intraperitoneal
injection of an aqueous suspension of cell wall fragments isolated from group A strepto-
cocci. Arthritis could be induced in rats which had been immunologically compromised by
neonatal thymectomy. Delayed hypersensitivity to cell wall peptidoglycan could not be
elicited in these rats, although progressive joint disease was obvious by clinical and
radiological measurements. A delayed skin test was elicited with peptidoglycan in non-
thymectomized rats at 6 to 14 days after injection of low doses of cell wall fragments.
Between 2 to 4 weeks after cell wall injection the skin test could not be elicited and these
rats could not be sensitized again with peptidoglycan. After a high dose ofcell wall the skin
test could not be elicited at any time. These non-thymectomized rats which had been
injected with cell walls remained hyporesponsive to peptidoglycan for at least 3 months.
Lymphocytes from non-thymectomized cell wall-injected rats also showed a non-specific
depression of lymphocyte response to phytohaemagglutinin in vitro, but this function was
recovered between 2 to 4 weeks after cell wall injection. We conclude that cell-mediated
immunity against bacterial cell wall antigens is not a pathogenetic factor in this experi-
mental model of arthritis.
INTRODUCTION
Chronic, remittent polyarthritis is produced in rats by a single intraperitoneal or intravenous
injection of a sterile aqueous suspension of cell wall fragments isolated from group A streptococci
(Cromartie et al., 1977). The disease evolves over a period of 4 to 6 months with repeated cycles of
remission and exacerbation involving most joints of the feet, ankles, wrists and knees. The
progressive injury, which leads to loss of function with extensive destruction ofjoint surfaces and
subchondral bone, has been monitored by histological and radiological analyses (Clark et al., 1979;
Cromartie et al., 1977).
This experimental model oferosive synovitis is an extension ofour studies on chronic inflamma-
tion induced by bacterial cell wall debris which the host cannot eliminate effectively (Ohanian,
Schwab & Cromartie, 1969; Schwab et al., 1967). The essential cell wall structure is the covalently
bound peptidoglycan-polysaccharide complex (Abdulla & Schwab, 1966; Schwab, Cromartie &
Roberson, 1959). An outstanding property of cell wall isolated from group A streptococci is its
resistance to biodegradation and consequent persistence in tissue (Ohanian & Schwab, 1967;
Schwab & Ohanian, 1967). In addition, the isolated peptidoglycan moiety is toxic (Abdulla &
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Schwab, 1966; Heymer & Rietschell, 1977); it can activate the alternate complement pathway
(Greenblatt, Boackle & Schwab, 1978); and it can stimulate macrophages to become cytotoxic
(Smialowicz & Schwab, 1977).
Because the peptidoglycan and polysaccharide moieties of group A streptococcal cell walls are
antigenic, analysis of the mechanisms of tissue injury must consider the role of specific immune
responses against these structures. Therefore, we have measured delayed hypersensitivity and the
evolution of joint disease after cell wall injection in normal rats and in rats compromised by
neonatal thymectomy. The rationale is based upon observations that an adult rat, thymectomized
at birth, has an impaired capacity to develop delayed hypersensitivity and other manifestations of
cell-mediated immunity (Arnason et al., 1962; McCullogh, 1976), although neonatal thymectomy
does not completely deprive a rat of thymus-derived cells (McCullogh, 1976).
This paper reports our studies on: (i) the effect of neonatal thymectomy upon the experimental
model of rheumatoid arthritis in the rat, and the influence of cell wall dose upon the effect of
thymectomy; (ii) the relationship ofjoint disease to delayed hypersensitivity against peptidoglycan;
and (iii) the development of cell-mediated immune hyporesponsiveness in non-thymectomized rats
injected with cell wall fragments. Antibody responses to cell wall antigens are described in an
accompanying paper (Greenblatt, Hunter & Schwab, 1980).
MATERIALS AND METHODS
Animals. Outbred, Sprague-Dawley rats were purchased from Zivic-Miller, Allison Park,
Pennsylvania. Animals from this stock were bred in our animal facilities and neonatal thymectomy
was performed within 24 hr ofbirth by splitting the sternum vertically and removing each lobe of the
thymus by a combination of blunt dissection and suction. Littermates were matched for thymec-
tomy or sham thymectomy. Males and females were included in both groups. Tetracycline (Lederle)
was added to the drinking water of all rats (mothers and weaned rats) throughout the experiment in
a concentration of 250 mg/I (estimated to be 8 mg rat-day-). When the animals reached an
average weight of 150 g (about 7 weeks old) they were given one intraperitoneal (i.p.) injection with
a sterile suspension of cell wall fragments in pH 7 2 phosphate-buffered saline (PBS).
Bacterial cells and cell walls. The details of these procedures have been described previously
(Cromartie et al., 1977; Ohanian & Schwab, 1967). Group A, type 3, strain D-58 streptococci were
grown in Todd-Hewitt broth (DIFCO, Detroit, Michigan) for 16 hr at 37 C. The cells were harvested
by centrifugation, washed and disrupted in a Braun shaker (Bronwell Scientific Co., Rochester,
New York). Cell walls were collected by differential centrifugation, treated with trypsin and
ribonuclease and washed five times. Cell wall fragments were prepared by suspending cell walls in
pH 7 2 PBS and subjecting them to sonic treatment for 70 min in a Branson sonifier (Heat
Systems-Ultrasonics, Plainview, New York). After sonication the walls were filtered through a
millipore 0-45-pm filter (Millipore Corp., Bedford, Massachusetts) and the concentration of
rhamnose, N-acetyl glucosamine and N-acetyl muramic acid measured by gas chromatography.
Sterility was confirmed by culture on blood agar plates.
Design ofexperiments. This study was designed to obtain periodic assessment ofjoint disease by
clinical and radiological measurements, skin test reactions to peptidoglycan, and in vitro response of
lymph node cells to stimulation by phytohaemagglutinin (PHA, DIFco Laboratories, Detroit,
Michigan). All of these measurements were compared in neonatally thymectomized and non-thy-
mectomized rats injected with different doses of cell wall fragments. Sixty-two thymectomized and
thirty-five non-thymectomized rats were injected with cell wall fragments in a dose of 60 mg of
rhamnose per g body weight. More thymectomized rats were injected because we anticipated a
higher death rate in this group. A higher incidence of death, however, did not occur. At intervals of
3, 15, 30, 56 and 86 days after injection, randomly selected groups of five to ten thymectomized and
five to ten non-thymectomized rats were skin tested, by intradermal (i.d.) injection on the flank, with
50 pg of peptidoglycan isolated from group A variant streptococcal cell walls (Abdulla & Schwab,
1966). The diameter and thickness of induration of the skin site were measured at 6, 24 and 48 hr
after i.d. injection. The skin test score is the sum of thickness and induration in mm. These rats were
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then bled and killed with ether. Four thymectomized and four non-thymectomized rats not injected
with cell walls were included with each group. Aortic, inguinal and mesenteric lymph nodes were
collected for tissue culture of lymphocytes in order to study the in vitro response to PHA.
The effect of cell wall dose upon the skin test reaction to peptidoglycan and joint lesion
development in thymectomized and non-thymectomized rats were also studied. These measure-
ments were done at intervals on forty-nine thymectomized rats and forty-one non-thymectomized
rats injected with 20 pg of cell wall rhamnose per g of body weight, and on ten thymectomized and
ten non-thymectomized rats injected with 5 jug of cell wall rhamnose per g of body weight. At the
termination of all experiments all surviving rats were skin tested, bled and radiographed.
Evaluation ofjoint disease. All rats were observed daily during the first 3 weeks after cell wall
injection and three to four times per week thereafter until termination of the experiments at 3
months. The severity was graded using a scale of 0 to 4 for each leg (maximum score 16). The score
was based on the severity and extent of erythema and oedema of the periarticular tissues and the
enlargement, distortion or ankylosis of the joints. The maximum acute joint lesion score was the
greatest score recorded up to 16 days after cell wall injection (usually this score was achieved at 3 to 7
days after injection). The maximum chronic joint lesion score was the highest observed after 16 days
following cell wall injection (usually between 20 to 60 days). Joint lesions were also assessed by
X-ray and scored by a radiological technique described by Clark et al. (1979). The clinical and
radiological evaluations were made by different individuals who were not aware of the other scoring
results.
Evaluation of thymectomy. When rats were killed an estimate of gross thymic remnants was
recorded. The tissue in the mediastinal region was fixed in formalin and serial histological sections
prepared for microscopic examination. From the microscopic study 66% of the rats had no
detectable thymus, 18% had 10% estimated thymus remnants, 9% had 20% thymus remnants and
6% had 30% thymus remaining. Animals with more than 10% thymus were not included in the
calculations. In agreement with others (Arnason et al., 1962) we did not see any consistent
difference in measurements of thymic function between rats with 0 to 20% thymus remnants.
Thymic function was evaluated in the groups of thymectomized and normal rats which were
killed at 3, 15, 30, 56 or 86 days after injection of cell walls. Thymectomized and normal control rats
(not injected with cell walls) were included. Most of the remaining rats were also evaluated when
they were killed at the termination of the experiments. A measurement of function was the response
of lymph node cells to stimulation by PHA. Cell suspensions from cervical, axillary and inguinal
lymph nodes were prepared in RPMI 1640 tissue culture medium supplemented with 10% heat-inac-
tivated foetal calf serum, 25 mm HEPES buffer, 0 I% glutamine and 0 1 mg/ml of gentamicin. Cells
were cultured in Falcon culture plates (3040) in a concentration of 1 x 106 cells per well. Cells from
each animal were tested separately in quadruplicate with PHA in concentrations of 1, 5 or 10 ug per
well. Cultures were incubated for 72 hr in 5% CO2 at 37°C and 3H-thymidine added for the last 12 hr
of culture. Cells were harvested with a Mash II Cell Harvester and the incorporated radioactivity
measured in a Packard liquid scintillation counter.
The net counts per min (c.p.m.) of lymphocytes from neonatally thymectomized control rats
killed at each of the five intervals was 11 to 20% of the values of the normal control rats. As a further
test of the thymectomy procedure, sixteen normal control rats and sixteen thymectomized control
rats were sensitized to tuberculin by injecting a hind footpad with 0-05 ml of Freund's complete
adjuvant (DIFCO) to which 6 mg/ml of additional Mycobacterium butyricum had been added.
Twelve days later a delayed skin test reaction was elicited by i.d. injections of 250 units of PPD
(purified protein derivative). The average diameter of induration at 24 hr in the normal group was
8-6 mm compared with 2 8 mm for the thymectomized group (P <0.01).
Delayed skin test reaction to peptidoglycan. The isolated peptidoglycan polymer is a
dermonecrotoxin (Abdulla & Schwab, 1966) and therefore must be detoxified to an acceptable level
to be used as an eliciting skin test antigen. This is done by reducing the polymer size by limited
lysozyme digestion or sonication (Abdulla & Schwab, 1966).
Conditions of sonication optimal for reducing toxicity while retaining antigenicity were deter-
mined in preliminary experiments. For the present study 8 5 mg of peptidoglycan isolated from cell
walls of group A-variant streptococci, strain K-43, were suspended in 17 ml of PBS and sonicated
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for 20 min in a Branson sonifier using a 20-ml steel cup and a j-inch probe. When injected
intradermally into the flank of control rats in a dose of 50 pg an acute inflammatory reaction was
produced which reached a peak response between 12 to 24 hr and then subsided. This reflects the
residual toxicity of the peptidoglycan and all reactions were read against this background. When the
peptidoglycan was injected intradermally into rats sensitized by either an i.p. injection of an
aqueous suspension of cell walls, or by cell walls in Freund's complete adjuvant, a peak response
was reached at 48 hr. Microscopic examination of biopsies of the skin test site showed histological
features consistent with reactions to tuberculin in tuberculin-sensitized rats (Arnason et al., 1962).
On the basis of these observations we consider this a delayed hypersensitivity (DH) reaction to
peptidoglycan. The skin reaction elicited with group A cell walls (peptidoglycan-polysaccharide
complex) was not consistent, and the isolated group A polysaccharide elicited no reaction.
Normal control rats can also be sensitized by an i.d. injection of 50 pg of peptidoglycan. A
delayed skin reaction, which reaches a peak in 48 hr, can be elicited by a second i.d. injection of 50 pg
ofpeptidoglycan given within 6 to 9 days after the first injection. If rats are skin tested with a second
or third i.d. injection of peptidoglycan after an interval greater than 12 days between injections, no
reaction is elicited. This reaction resembles a cutaneous basophil hypersensitivity (CBH) or
Jones-Mote reaction more than a DH reaction in the method of induction and the transient state of
sensitivity (Dvorak, 1976). Unlike CBH in guinea-pigs, the reaction in rats has some induration and
very few basophils. The important point, however, is that while CBH and DH may have distinguish-
ing features, both are delayed cell-mediated immunological reactions (Dvorak, Colvin & Churchill,
1975).
RESULTS
Effect ofcell wall dose and neonatal thymectomy on arthritis
The incidence and severity of joint disease was dose-related. Intraperitoneal injection of outbred
Sprague-Dawley rats with 60 pg of cell wall rhamnose per g of body weight induced both the acute
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Fig. 1. The course ofjoint disease in neonatally thymectomized and non-thymectomized rats injected i.p. with an
aqueous suspension of cell wall fragments from group A streptococci in a dose ofeither 20 or 60 pg ofrhamnose
per g body weight (.*-) Non-thymectomized and (o --- o) thymectomized with 60-pg dose; (n-u) non-thy-
mectomized and (a --- a) thymectomized with 20-pg dose. (*) Significant difference between thymectomized
and non-thymectomized group at P < 0 05. In the animals given a dose of60 pg ofcell wall rhamnose per g body
weight there were initially sixty-two rats included in the thymectomized group, decreasing to twenty-eight as
animals were removed for skin testing or histopathology; in the non-thymectomized group, there were initially
thirty-five rats decreasing to fourteen. With the 20-pg dose there were forty-nine thymectomized decreasing to
thirty-seven and forty-one non-thymectomized decreasing to thirty-five.
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in rats injected with 20 pg ofcell wall rhamnose per g body weight, and 10% in rats injected with 5 pg
cell wall rhamnose per g body weight. Typically, there was an early acute inflammation of the joint
which appeared within 1 to 2 days after cell wall injection and reached a peak at 3 to 5 days. This
early reaction receded by 2 weeks and was followed by the chronic phase consisting of a series of
remissions and exacerbations continuing for at least 3 months.
The effect of neonatal thymectomy on the clinical course of disease is shown in Fig. 1, and the
terminal radiograph scores of the hind legs in Fig. 2. The correlation between clinical and
radiograph scores was high (r=0 84, n =97, P <0O0001). It is evident that joint disease developed in
thymectomized rats in spite ofimpaired T cell function. With a relatively high dose (60 pg ofcell wall
rhamnose per g) there was no difference in the acute phase of the disease over the first 2 weeks. As
the disease progressed into the chronic, remittent phase the joint scores were greater in the
thymectomized group at several intervals. However, after 60 days the difference between thymecto-
mized and non-thymectomized rats was not significant (Fig. 1). This was confirmed by the terminal
radiograph scores (Fig. 2).
8
00
14 as* 00 0
00
is12 - . Go
-5
lo- O




0 00 . 00
fir 4 - . 0
2 - 0 0
GM 0
N60T N 20T N 5 T N 0 T
Rhamnose (jig per g body weight)
Fig. 2. Terminal radiographic scores of joint lesions in hind limbs of neonatally thymectomized (T) and
non-thymectomized (N) rats injected with cell wall fragments. All rats surviving to day 86 are included. Each
point represents one rat.
Thymectomized rats given a dose of 20 pg of cell wall rhamnose per g of body weight developed
lower joint scores than non-thymectomized animals in both the acute and chronic phases, but
because of the large variance, the difference between the groups was inconsistent and statistically
significant at only a few intervals (Fig. l). The terminal radiograph scores also failed to show a
significant difference between these groups (Fig. 2). Injection of 5 pg of cell wall rhamnose per g
body weight produced clinically apparent arthritis in one out of ten rats in both thymectomized and
non-thymectomized groups. The incidence was higher in the thymectomized group by radiographic
measurement, but the difference was not significant (Fig. 2).
Relationship ofarthritis to delayed skin tests
From the non-thymectomized rats injected i.p. with cell walls in a dose of 60 pg of rhamnose per g
body weight, groups of five to ten were randomly selected for skin testing with 50 pg of peptidogly-
can at intervals after cell wall injection. In the group ofrats injected with cell walls in a dose of 5 or 20
pg ofrhamnose per g body weight, the same rats were skin tested at each time interval. The course of
joint disease in these rats is depicted in Fig. 1. The skin test scores at 48 hr after peptidoglycan
injection are shown in Fig. 3. The rats injected with cell wall doses of 5 or 20 pg of rhamnose per g
body weight developed delayed reactions significantly different from controls (P<0-0l) when
skin-tested with peptidoglycan for the first time at 7 days after cell wall injection. Thereafter the
reaction was no greater than control rats not injected with cell wall. Rats given the high dose of cell
wall (60 pg of rhamnose per g body weight) did not display any delayed reaction at any time, and in
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Fig. 3. Delayed skin test responses to peptidoglycan by non-thymectomized rats which had been injected i.p.
with an aqueous suspension of cell wall fragments. Skin tests were elicited with 50 pg of peptidoglycan at
intervals of 7 to 90 days after i.p. injection of cell walls in doses of 5 (o), 20 (&) or 60 (o) pg of rhamnose per g body
weight. The number by each point is the number of rats skin tested in each group. Probability values are given for
points which are significantly different from the control group skin-tested at the same interval. The horizontal
lines indicate the mean skin test score + I standard deviation for all control animals. The joint scores of the
groups from which these rats were taken for skin testing are shown in Fig. 1.
Table 1. Anergy to peptidoglycan in non-thymectomized rats injected with cell wall fragments*
Interval
between i.d. Skin test Level of
No. of i.d. injections No. of score significance
Groupt injections (days) rats (mm)+ (P vs control 1)
Control 1 2 7 32 16 4 + 2 5
Cell wall (60pg) 2 7 8 1-6 +0 8 <0001
Cell wall (20ug) 2 7 5 6 2 + 2 3 < 0 05
Cell wall (5 fpg) 2 7 5 8.7 + 2 8 n.s.
Control2 1 68 70+1-1 <0001
Control3 2 21 10 72+19 <001
Control 4 (CW + FCA) 1 7 20 0+ 2 9 n.s.
2 21 7 208+32 n.s.
* Anergy is measured by sensitization of rats for a delayed skin test reaction to
peptidoglycan. Rats were sensitized by an i.d. injection of 50 Pg of peptidoglycan. The
reaction was elicited 7 days later with a second i.d. injection of 50 Pg of peptidoglycan.
t Controls 1, 2 and 3 are normal rats not injected with cell wall; cell wall indicates rats
injected i.p. 54 days earlier with cell wall fragments in doses of 60, 20 or 5 Pg of rhamnose
per g body weight; control 4 is the group of rats sensitized with cell wall in Freund's
complete adjuvant and skin-tested with peptidoglycan 12 and 33 days latter (21-day
interval between skin tests).
I Mean + s.e. of induration at 48 hr.
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fact the measurements were significantly below control rats when tested at intervals from 30 to 80
days after cell wall injection (Fig. 3).
In order to confirm that these cell wall-injected rats were anergic to peptidoglycan, we attempted
to re-stimulate them for a delayed skin reaction as described in the Materials and Methods section.
Rats were sensitized by an i.d. injection of peptidoglycan and the delayed reaction was elicited 7
days later with a second i.d. injection ofpeptidoglycan. In contrast to control rats, cell wall-injected
rats were difficult to sensitize by this procedure and the degree of anergy was directly related to the
dose of cell wall which had been injected (Table 1).
The neonatally thymectomized rats injected with the same doses of cell wall failed to develop
delayed skin reactions at any time after cell wall injection, including the rats injected with the low
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Fig. 4. Delayed skin test responses to peptidoglycan by neonatally thymectomized rats which had been injected
with cell wall fragments in doses of 60(o), 20 (el); or 5 (o) pg of rhamnose per g body weight. (See legend to Fig. 3
for key.)
Table 2. Effect of cell wall injection upon in vitro stimulation of rat lymph node cells by PHA
Days after cell
wall injection Group* No. of rats Net c.p.m.t
3 Control 4 5,564+ 84
Cell wall 6 469+ 33
15 Control 4 5,521 +86
Cell wall 6 1,145+32
30 Control 4 8,177+ 47
Cell wall 5 8,498+ 106
56 Control 5 5,404+21
Cell wall 5 8,688 + 94
86 Control 14 10,914+ 112
Cell wall 13 11,562 + 137
* Non-thymectomized rats, either not injected with
cell wall (control) or injected i.p. with cell wall fragments
in a dose of 60 ,g of rhamnose per g body weight.
t Incorporation of 3H-thymidine, counts per min
(c.p.m.) in cultures with 5 jg of PHA, less c.p.m. in
cultures without PHA.
, * * . j . .
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effectiveness of the neonatal thymectomy. At the low cell wall doses the skin reactions at 7 days after
cell wall injection were significantly less than those of non-thymectomized rats (compare Figs 3 and
4). It is noteworthy that the skin test responses ofthymectomized rats given cell walls in a dose of60
ug of rhamnose per g body weight were not significantly greater than the thymectomized controls
but were greater than the comparable non-thymectomized rats given the same cell wall dose. This
was consistently observed for 60 days after injection. There was no significant difference between
thymectomized control rats (not injected with cell wall) and non-thymectomized control rats in the
skin test responses (Figs 3 and 4). Regression analysis of maximum chronic joint lesion scores
(achieved between 16 to 90 days after cell wall injection) and delayed skin tests in individual rats,
measured at 7 days after injection of cell walls in a dose of 20 Mg of rhamnose per g body weight,
showed no correlation.
Effect of cell wall injection upon lymphocyte function
Lymph node cells from non-thymectomized rats injected with cell walls in a dose of 60 Mg of
rhamnose per g body weight had a reduced capacity to respond to PHA stimulation when removed
3 or 15 days after cell wall injection. This function returned to the normal level by 30 days (Table 2).
DISCUSSION
Both neonatally thymectomized and non-thymectomized rats injected i.p. with group A streptococ-
cal cell wall fragments developed chronic, remittent, erosive arthritis in spite of impaired T cell
function. The impairment of cell-mediated immunity was ascertained by a reduced mitogenic
response of lymphocytes to PHA and absence of a delayed skin test reaction to peptidoglycan. We
conclude that cell-mediated immune responses against bacterial cell wall antigens are not essential
in the pathogenesis of this model of experimental arthritis.
Thymectomy of rats has been employed in the analysis of other models of experimental disease
which are proposed to have a delayed hypersensitivity component. Arnason et al. (1962) reported
that adjuvant arthritis was not influenced by neonatal thymectomy. Lennon & Byrd (1973) showed
that experimental allergic encephalomyelitis was suppressed by neonatal thymectomy, but the
incidence of adjuvant arthritis in the same rats was greatly increased. Somewhat analogous to our
results is the report that thymectomy of rats at 4 weeks of age enhanced induction of adjuvant
arthritis with high, but not with low, doses of wax D (Kayashima, Toshitaka & Onoue, 1976). It
must be noted that the model reported here has several features which distinguish it from adjuvant
arthritis, which is induced with cell wall structures in oil and has a different clinical course. Hadler &
Granovetter (1978) have recently reviewed and compared the features of various models of arthritis
induced with bacteria.
An interesting aspect of this study was the finding that non-thymectomized rats injected with cell
walls also developed an impaired cellular immune capacity while the joint disease was evolving. The
mechanism of this depressed immune function is being investigated. It could be related to the splenic
suppressor macrophage described in rats by Oehler et al. (1977). We do not know if this hypores-
ponsiveness, or anergy, is a factor in the development ofexperimental arthritis. A deficient immune
response could affect distribution or persistence of cell wall material. Hyporesponsiveness has also
been reported in patients with rheumatoid arthritis (Andrianakos et al., 1977; Waksman et al.,
1975).
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